Live feed17:05:00·64dPRReleasevia QuantisnowTARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder CancerByQuantisnow·Wall Street's wire, on your screen.TARA· Protara Therapeutics Inc.Health Care
